Cancer Research Prevention Award  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 2015, March 1, 2007. doi: 10.1158/0008-5472.CAN-06-3617
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chun, K.-S.
Right arrow Articles by Langenbach, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chun, K.-S.
Right arrow Articles by Langenbach, R.

Molecular Biology, Pathobiology, and Genetics

Cyclooxygenase-2 Inhibits UVB-Induced Apoptosis in Mouse Skin by Activating the Prostaglandin E2 Receptors, EP2 and EP4

Kyung-Soo Chun, Jacqueline K. Akunda and Robert Langenbach

Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina

Requests for reprints: Robert Langenbach, National Institute of Environmental Health Sciences, M. D. C4-09, P.O. Box 12233, Research Triangle Park, NC 27709. Phone: 919-541-7558; Fax: 919-541-1460; E-mail: langenb1{at}niehs.nih.gov.

Cyclooxygenase-2 (COX-2) is induced by UVB light and reduces UVB-induced epidermal apoptosis; however, the mechanism is unclear. Therefore, wild-type (WT) and COX-2–/– mice were acutely treated with UVB (5 kJ/m2), and apoptotic signaling pathways were compared. Following exposure, apoptosis was 2.5-fold higher in COX-2–/– compared with WT mice. Because prostaglandin E2 (PGE2) is the major UV-induced prostaglandin and manifests its activity via four receptors, EP1 to EP4, possible differences in EP signaling were investigated in WT and COX-2–/– mice. Following UVB exposure, protein levels of EP1, EP2, and EP4 were elevated in WT mice, but EP2 and EP4 levels were 50% lower in COX-2–/– mice. Activated cyclic AMP-dependent protein kinase (PKA) and Akt are downstream in EP2 and EP4 signaling, and their levels were reduced in UVB-exposed COX-2–/– mice. Furthermore, p-Bad (Ser136 and Ser155), antiapoptotic products of activated Akt and PKA, respectively, were significantly reduced in UVB-exposed COX-2–/– mice. To further study the roles of EP2 and EP4, UVB-exposed CD-1 mice were topically treated with indomethacin to block endogenous PGE2 production, and PGE2, the EP2 agonist (butaprost) or EP4 agonist (PGE1 alcohol), was applied. Indomethacin reduced PKA and Akt activation by ~60%, but PGE2 and the agonists restored their activities. Furthermore, both agonists decreased apoptosis in COX-2–/– mice by 50%. The data suggest that COX-2–generated PGE2 has antiapoptotic roles in UVB-exposed mouse skin that involves EP2- and EP4-mediated signaling. [Cancer Res 2007;67(5):2015–21]




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Steinert, C. Kuper, H. Bartels, F.-X. Beck, and W. Neuhofer
PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling
Am J Physiol Cell Physiol, January 1, 2009; 296(1): C75 - C87.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. M. Ansari, J. E. Rundhaug, and S. M. Fischer
Multiple Signaling Pathways Are Responsible for Prostaglandin E2-Induced Murine Keratinocyte Proliferation
Mol. Cancer Res., June 1, 2008; 6(6): 1003 - 1016.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Miyamoto, Y. Yasui, M. Kim, S. Sugie, A. Murakami, R. Ishigamori-Suzuki, and T. Tanaka
A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies
Carcinogenesis, February 1, 2008; 29(2): 418 - 426.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. A. Narayanan, B. S. Reddy, M. C. Bosland, D. Nargi, L. Horton, C. Randolph, and N. K. Narayanan
Exisulind in Combination with Celecoxib Modulates Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Cyclin D1 against Prostate Carcinogenesis: In vivo Evidence
Clin. Cancer Res., October 1, 2007; 13(19): 5965 - 5973.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
P. Agostinis, M. Garmyn, and A. Van Laethem
The Aryl Hydrocarbon Receptor: An Illuminating Effector of the UVB Response
Sci. Signal., September 11, 2007; 2007(403): pe49 - pe49.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.